MedPath

成都地奥九泓制药厂

Ownership
-
Established
1996-11-27
Employees
-
Market Cap
-
Website
http://www.diao.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

42

NMPA:42

Drug Approvals

Nicorandil for Injection

Product Name
注射用尼可地尔
Approval Number
国药准字H20254093
Approval Date
May 13, 2025
NMPA

Nicardipine Hydrochloride Injection

Product Name
盐酸尼卡地平注射液
Approval Number
国药准字H20253422
Approval Date
Feb 20, 2025
NMPA

Levosimendan Injection

Product Name
左西孟旦注射液
Approval Number
国药准字H20243548
Approval Date
Apr 17, 2024
NMPA

慢肾宁合剂

Approval Number
国药准字Z20013091
Approval Date
Mar 22, 2024
NMPA

慢肝解郁胶囊

Approval Number
国药准字Z19983133
Approval Date
Mar 22, 2024
NMPA

灵芝胶囊

Approval Number
国药准字Z19983035
Approval Date
Mar 22, 2024
NMPA

脂必妥片

Approval Number
国药准字Z20025688
Approval Date
Feb 6, 2024
NMPA

脂必泰胶囊

Approval Number
国药准字Z51022196
Approval Date
Feb 6, 2024
NMPA

Azilsartan Tablets

Product Name
阿齐沙坦片
Approval Number
国药准字H20223578
Approval Date
Aug 10, 2022
NMPA

Azilsartan Tablets

Product Name
阿齐沙坦片
Approval Number
国药准字H20223577
Approval Date
Aug 10, 2022
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.